Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Time to Buy?

Hypermarcas (OTCMKTS:HYPMY) shares gapped up prior to trading on Monday . The stock had previously closed at $3.96, but opened at $4.1125. Hypermarcas shares last traded at $4.1125, with a volume of 218 shares.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Hypermarcas presently has an average rating of “Buy”.

Hypermarcas Trading Down 0.7%

The firm has a market cap of $2.86 billion, a P/E ratio of 8.46 and a beta of 0.71. The business’s fifty day simple moving average is $4.28 and its 200-day simple moving average is $4.39.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. The firm had revenue of $383.13 million during the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. Analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.